Literature DB >> 9847246

Glycogen synthase kinase-3 (GSK-3) is regulated during Dictyostelium development via the serpentine receptor cAR3.

S E Plyte1, E O'Donovan, J R Woodgett, A J Harwood.   

Abstract

Glycogen synthase kinase-3 (GSK-3) is required during metazoan development to mediate the effects of the extracellular signal wingless/Wnt-1 and hence is necessary for correct cell type specification. GSK-3 also regulates cell fate during Dictyostelium development, but in this case it appears to mediate the effects of extracellular cAMP. By direct measurement of GSK-3 kinase activity during Dictyostelium development, we find that there is a rise in activity at the initiation of multicellular development which can be induced by cAMP. The timing of the rise correlates with the requirement for the Dictyostelium homologue of GSK-3, GSKA, to specify cell fate. We show that loss of the cAMP receptor cAR3 almost completely abolishes the rise in kinase activity and causes a mis-specification of cell fate that is equivalent to that seen in a gskA- mutant. The phenotype of a cAR3(-) mutant however is less severe than loss of gskA and ultimately gives rise to an apparently wild-type fruiting body. These results indicate that in Dictyostelium extracellular cAMP acts via cAR3 to cause a rise in GSKA kinase activity which regulates cell type patterning during the initial stages of multicellularity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847246     DOI: 10.1242/dev.126.2.325

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  20 in total

1.  Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.

Authors:  X Fang; S X Yu; Y Lu; R C Bast; J R Woodgett; G B Mills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

3.  Combinatorial cell-specific regulation of GSK3 directs cell differentiation and polarity in Dictyostelium.

Authors:  Leung Kim; Joseph Brzostowski; Amit Majithia; Nam-Sihk Lee; Vanessa McMains; Alan R Kimmel
Journal:  Development       Date:  2011-02       Impact factor: 6.868

4.  Evolution of the Wnt pathways.

Authors:  Jenifer C Croce; David R McClay
Journal:  Methods Mol Biol       Date:  2008

5.  Folic Acid Protects Against Glutamate-Induced Excitotoxicity in Hippocampal Slices Through a Mechanism that Implicates Inhibition of GSK-3β and iNOS.

Authors:  Josiane Budni; Simone Molz; Tharine Dal-Cim; Maria Dolores Martín-de-Saavedra; Javier Egea; Manuela G Lopéz; Carla Ines Tasca; Ana Lúcia Severo Rodrigues
Journal:  Mol Neurobiol       Date:  2017-02-10       Impact factor: 5.590

Review 6.  Pharmacogenetics in model systems: defining a common mechanism of action for mood stabilisers.

Authors:  Robin S B Williams
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-07       Impact factor: 5.067

7.  Glycogen Synthase Kinase 3β Is Positively Regulated by Protein Kinase Cζ-Mediated Phosphorylation Induced by Wnt Agonists.

Authors:  Nydia Tejeda-Muñoz; Héctor González-Aguilar; Paula Santoyo-Ramos; M Cristina Castañeda-Patlán; Martha Robles-Flores
Journal:  Mol Cell Biol       Date:  2015-12-28       Impact factor: 4.272

Review 8.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12

9.  Control of cyclin C levels during development of Dictyostelium.

Authors:  David M Greene; Duen-Wei Hsu; Catherine J Pears
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

10.  Glycogen synthase kinase-3 is required for efficient Dictyostelium chemotaxis.

Authors:  Regina Teo; Kimberley J Lewis; Josephine E Forde; W Jonathan Ryves; Jonathan V Reddy; Benjamin J Rogers; Adrian J Harwood
Journal:  Mol Biol Cell       Date:  2010-06-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.